Intravesical Cidofovir for Hemorrhagic Cystitis

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Blood And Marrow Transplantation
Interventions
DRUG

Cidofovir

2.5 mg/kg of cidofovir administered in 100 ml of normal saline solution through a transurethral catheter inside the bladder. The urinary catheter will be clamped for 2 hours.

DRUG

Probenecid

2 grams by mouth given approximately 3 hours prior to the bladder instillation of cidofovir.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER